| 24 May 2026 |
5-amino-1MQ |
8.4 |
30mg |
35.4mg |
+18.0% |
97.38% |
Lab C |
| 24 May 2026 |
BPC157 10mg + TB500 10mg Blend |
7.6 |
5mg |
6.1mg |
+21.3% |
97.14% |
Lab E |
| 24 May 2026 |
Botulinum toxin |
6.9 |
20mg |
17.4mg |
-12.9% |
95.95% |
Lab E |
| 24 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
4.2 |
30mg |
30.8mg |
+2.6% |
98.11% |
Lab C |
| 24 May 2026 |
CJC-1295 With DAC |
4.4 |
15mg |
15.6mg |
+3.7% |
99.39% |
Lab G |
| 24 May 2026 |
Phenylacetic acid CAS 103-82-2 |
6.5 |
100g |
94.9g |
-5.1% |
97.13% |
Lab B |
| 24 May 2026 |
AICAR |
6.0 |
30mg |
25.7mg |
-14.2% |
98.27% |
Lab F |
| 23 May 2026 |
KPV |
4.0 |
50mg |
59.6mg |
+19.2% |
96.75% |
Lab A |
| 20 May 2026 |
Orforglipron |
5.4 |
50mg |
42.6mg |
-14.7% |
98.56% |
Lab C |
| 20 May 2026 |
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 |
4.2 |
5g |
4.9g |
-1.2% |
99.33% |
Lab B |
| 20 May 2026 |
T3 (Liothyronine) |
5.1 |
10mg |
8.8mg |
-12.1% |
99.10% |
Lab B |
| 20 May 2026 |
Winstrol Oil |
4.6 |
300mg/ml |
310.5mg/ml |
+3.5% |
98.74% |
Lab E |
| 19 May 2026 |
N-Acetyl Epitalon Amidate |
7.9 |
20mg |
22.1mg |
+10.4% |
96.67% |
Lab D |
| 29 Jan 2026 |
Crystagen |
10.0 |
10mg |
11.7mg |
+16.7% |
99.20% |
Lab F |
| 26 Jan 2026 |
Aromasin (Exemestane) |
4.6 |
50mg |
52.3mg |
+4.6% |
99.71% |
Lab E |
| 19 Jan 2026 |
Vilon |
5.2 |
10mg |
12.5mg |
+24.5% |
97.14% |
Lab D |
| 9 Jan 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
9.1 |
15mg |
13.4mg |
-10.7% |
97.07% |
Lab F |
| 7 Jan 2026 |
Drostanolone Enanthate (Mast E) Raw |
5.3 |
5g |
5.0g |
-0.3% |
98.11% |
Lab G |
| 6 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.6 |
30mg |
29.3mg |
-2.3% |
98.11% |
Lab A |
| 29 Dec 2025 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
6.7 |
2mg |
1.7mg |
-14.8% |
98.23% |
Lab C |
| 12 Dec 2025 |
AICAR Oral |
4.4 |
20mg |
24.2mg |
+21.1% |
98.65% |
Lab E |
| 12 Dec 2025 |
EPO |
5.1 |
30mg |
30.6mg |
+1.9% |
97.21% |
Lab F |
| 12 Dec 2025 |
Prostamax |
5.6 |
15mg |
18.4mg |
+22.5% |
98.97% |
Lab C |
| 5 Dec 2025 |
Lipo-B 216mg |
4.3 |
100mg/ml |
95.3mg/ml |
-4.7% |
95.28% |
Lab F |
| 17 Nov 2025 |
MOTS-C |
5.7 |
30mg |
28.5mg |
-4.9% |
97.00% |
Lab B |
| 14 Nov 2025 |
GHRP-6 Acetate |
4.3 |
50mg |
45.3mg |
-9.3% |
97.05% |
Lab C |
| 5 Nov 2025 |
ACE-031 |
5.7 |
30mg |
34.8mg |
+16.2% |
99.35% |
Lab D |
| 5 Nov 2025 |
Lipo-C 120mg |
6.9 |
100mg/ml |
115.8mg/ml |
+15.8% |
98.69% |
Lab F |
| 5 Nov 2025 |
Semaglutide Oral |
4.9 |
25mg |
21.9mg |
-12.5% |
95.72% |
Lab D |
| 4 Nov 2025 |
Pinealon |
8.7 |
2mg |
2.4mg |
+21.8% |
95.81% |
Lab F |
| 4 Nov 2025 |
Retatrutide Raw |
4.8 |
5g |
5.0g |
+0.2% |
95.50% |
Lab G |
| 4 Nov 2025 |
Sustanon Blend Raw |
4.0 |
100g |
93.2g |
-6.8% |
96.77% |
Lab G |
| 16 Mar 2025 |
PT-141 |
|
2.5 |
10mg |
8.08mg |
-19.2% |
White Label / Silver Crimp / Blue Cap |
| 21 Feb 2025 |
CJC-1295 |
No DAC |
6.6 |
2mg |
2.03mg |
+1.5% |
White Label / Silver Crimp / Red Cap |
| 19 Feb 2025 |
Melanotan II |
|
5.4 |
10mg |
11.14mg |
+11.4% |
White Label / Silver Crimp / Red Cap |
| 19 Feb 2025 |
BPC-157 |
|
4.4 |
5mg |
8.34mg |
+66.8% |
White Label / Silver Crimp / Violet Cap |
| 19 Feb 2025 |
Retatrutide |
|
6.5 |
5mg |
5.45mg |
+9.0% |
White Label / Silver Crimp / Green Cap |
| 19 Feb 2025 |
Ipamorelin |
|
7.7 |
2mg |
1.99mg |
-0.5% |
White Label / Silver Crimp / Pink Cap |
| 19 Feb 2025 |
Semaglutide |
|
7.6 |
5mg |
5.15mg |
+3.0% |
White Label / Silver Crimp / Blue Cap |